{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:28:44Z","timestamp":1791962924608,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ophtha.2012.11.023","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T11:19:28Z","timestamp":1361186368000},"page":"1262-1270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Comparison of Treatment Regimens for Cytomegalovirus Retinitis in Patients with AIDS in the Era of Highly Active Antiretroviral Therapy"],"prefix":"10.1016","volume":"120","author":[{"given":"Douglas A.","family":"Jabs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Van Natta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2012.11.023_bib1","first-page":"623","article-title":"Ocular manifestations of HIV infection","volume":"93","author":"Jabs","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2012.11.023_bib2","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.ophtha.2010.03.031","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes","volume":"117","author":"Jabs","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.11.023_bib3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2010.10.018","article-title":"Cytomegalovirus retinitis and the acquired immune deficiency syndrome-bench to bedside: LXVII Edward Jackson Memorial Lecture","volume":"151","author":"Jabs","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.023_bib4","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/infdis\/166.6.1223","article-title":"Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine","volume":"166","author":"Gallant","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2012.11.023_bib5","first-page":"1069","article-title":"Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus","volume":"5","author":"Pertel","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ophtha.2012.11.023_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.1996.01100140035004","article-title":"Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression","volume":"114","author":"Hoover","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.023_bib7","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ajo.2011.11.014","article-title":"Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"153","author":"Sugar","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.023_bib8","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2012.11.023_bib9","first-page":"1931","article-title":"Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994\u20131997 [letter]","volume":"12","author":"Holtzer","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.ophtha.2012.11.023_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1086\/313612","article-title":"Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy","volume":"30","author":"Jacobson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ophtha.2012.11.023_bib11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ophtha.2006.11.008","article-title":"The Longitudinal Study of the Ocular Complications of AIDS: 1","volume":"114","author":"Jabs","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.11.023_bib12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0002-9394(98)00285-2","article-title":"Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy","volume":"126","author":"Jabs","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.023_bib13","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1086\/517399","article-title":"Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients","volume":"177","author":"Tural","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2012.11.023_bib14","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1086\/515281","article-title":"Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy","volume":"177","author":"Macdonald","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2012.11.023_bib15","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.282.17.1633","article-title":"Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis","volume":"282","author":"Whitcup","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2012.11.023_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-137-4-200208200-00008","article-title":"Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy","volume":"137","author":"Kirk","year":"2002","journal-title":"Ann Intern Med"},{"issue":"RR04","key":"10.1016\/j.ophtha.2012.11.023_bib17","first-page":"73","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ophtha.2012.11.023_bib18","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ajo.2011.04.007","article-title":"Evaluation of the United States Public Health Service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis","volume":"152","author":"Holbrook","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.023_bib19","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archopht.126.8.1143","article-title":"AIDS and ophthalmology, 2008","volume":"126","author":"Jabs","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.023_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199707103370203","article-title":"Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant","volume":"337","author":"Musch","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2012.11.023_bib21","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199904083401402","article-title":"Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant","volume":"340","author":"Martin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2012.11.023_bib22","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1086\/379077","article-title":"Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome","volume":"37","author":"Kempen","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"RR-17","key":"10.1016\/j.ophtha.2012.11.023_bib23","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ophtha.2012.11.023_bib24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ophtha.2006.07.065","article-title":"The Longitudinal Study of the Ocular Complications of AIDS: 2. Ocular examination results at enrollment","volume":"114","author":"Jabs","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.11.023_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0197-2456(92)90027-W","article-title":"Studies of Ocular Complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1","volume":"13","year":"1992","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ophtha.2012.11.023_bib26","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.ophtha.2004.05.031","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1","volume":"111","author":"Jabs","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.11.023_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0002-9394(82)90197-0","article-title":"New visual acuity charts for clinical research","volume":"94","author":"Ferris","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.023_bib28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ophtha.2010.09.017","article-title":"Visual field loss in patients with cytomegalovirus retinitis","volume":"118","author":"Thorne","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.11.023_bib29","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.ophtha.2004.05.028","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment","volume":"111","author":"Jabs","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.11.023_bib30","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archopht.1994.01090240037023","article-title":"Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant","volume":"112","author":"Martin","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.023_bib31","first-page":"213","article-title":"Practical Statistics for Medical Research","author":"Altman","year":"1991"},{"key":"10.1016\/j.ophtha.2012.11.023_bib32","first-page":"70","article-title":"Analysis of Survival Data","author":"Cox","year":"1984"},{"key":"10.1016\/j.ophtha.2012.11.023_bib33","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/sim.4780132105","article-title":"Cox regression analysis of multivariate failure time data: the marginal approach","volume":"13","author":"Lin","year":"1994","journal-title":"Stat Med"},{"key":"10.1016\/j.ophtha.2012.11.023_bib34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9394(98)00134-2","article-title":"Cytomegalovirus retinitis and viral resistance: 3","volume":"126","author":"Jabs","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.023_bib35","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/432012","article-title":"Cytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and occurrence of resistant CMV in patients with CMV retinitis","volume":"192","author":"Jabs","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2012.11.023_bib36","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ophtha.2004.10.049","article-title":"Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy","volume":"112","author":"Jabs","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.11.023_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9394(02)01759-2","article-title":"Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis","volume":"135","author":"Jabs","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.11.023_bib38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ophtha.2009.06.016","article-title":"Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS","volume":"117","author":"Jabs","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.11.023_bib39","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/514249","article-title":"Cytomegalovirus retinitis and viral resistance: ganciclovir resistance","volume":"177","author":"Jabs","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2012.11.023_bib40","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/AAC.42.9.2240","article-title":"Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis","volume":"42","author":"Jabs","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ophtha.2012.11.023_bib41","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1086\/512368","article-title":"Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis","volume":"44","author":"Martin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ophtha.2012.11.023_bib42","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0161-6420(94)31181-X","article-title":"Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial 4: Visual outcomes","volume":"101","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.11.023_bib43","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ophtha.2006.03.021","article-title":"Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"113","author":"Thorne","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.11.023_bib44","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ophtha.2006.03.022","article-title":"Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"113","author":"Thorne","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.11.023_bib45","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ophtha.2011.09.004","article-title":"Intravitreal ganciclovir maintenance injection for cytomegalovirus retinitis: efficacy of a low-volume, intermediate-dose regimen","volume":"119","author":"Teoh","year":"2012","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642012011025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642012011025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:04:52Z","timestamp":1758981892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642012011025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0161642012011025"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2012.11.023","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Treatment Regimens for Cytomegalovirus Retinitis in Patients with AIDS in the Era of Highly Active Antiretroviral Therapy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2012.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}